Insider Trading activities of Actinium Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Actinium Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Actinium Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Actinium Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ATNM. The reporting company's CIK number is 1388320.
The total value of stock buying since 2005 is $99,229.
The total value of stock sales since 2005 is $1,894,313.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Actinium Pharmaceuticals, Inc. (ATNM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 16,000 $18,381 0 $0 0 $0
2016-12 10,000 $9,300 0 $0 0 $0
2016-08 0 $0 252,395 $454,143 0 $0
2016-07 0 $0 174,880 $319,699 0 $0
2016-06 0 $0 110,673 $217,593 0 $0
2016-05 0 $0 205,804 $396,061 0 $0
2016-04 35,500 $71,153 249,074 $506,817 0 $0
2013-05 100 $395 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Actinium Pharmaceuticals, Inc. insiders (ATNM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-15 Berger Mark Stanley (Chief Medical Officer) Buy 5,000 1.11 5,550
2017-06-15 O'loughlin Steve (Principal Financial Officer) Buy 3,500 1.17 4,094
2017-06-15 Seth Sandesh (Chairman and CEO) Buy 7,500 1.17 8,737
2016-12-30 Seth Sandesh (Executive Chairman) Buy 5,000 .88 4,400
2016-12-12 Seth Sandesh (Executive Chairman) Buy 5,000 .98 4,900
2016-08-31 Memorial Sloan-kettering Cancer Center Sale 136,853 1.83 250,851
2016-08-30 Memorial Sloan-kettering Cancer Center Sale 56,074 1.81 101,493
2016-08-29 Memorial Sloan-kettering Cancer Center Sale 25,000 1.72 42,875
2016-08-26 Memorial Sloan-kettering Cancer Center Sale 25,000 1.71 42,625
2016-08-16 Memorial Sloan-kettering Cancer Center Sale 5,029 1.72 8,664
2016-08-15 Memorial Sloan-kettering Cancer Center Sale 4,439 1.72 7,635
2016-07-12 Memorial Sloan-kettering Cancer Center Sale 3,100 1.80 5,595
2016-07-11 Memorial Sloan-kettering Cancer Center Sale 800 1.80 1,440
2016-07-08 Memorial Sloan-kettering Cancer Center Sale 21,190 1.80 38,142
2016-07-06 Memorial Sloan-kettering Cancer Center Sale 10,500 1.80 18,900
2016-07-05 Memorial Sloan-kettering Cancer Center Sale 10,340 1.82 18,870
2016-07-01 Memorial Sloan-kettering Cancer Center Sale 128,950 1.84 236,752
2016-06-30 Memorial Sloan-kettering Cancer Center Sale 19,150 1.81 34,604
2016-06-15 Memorial Sloan-kettering Cancer Center Sale 33,619 1.90 63,876
2016-06-02 Memorial Sloan-kettering Cancer Center Sale 17,790 2.01 35,757
2016-06-01 Memorial Sloan-kettering Cancer Center Sale 40,114 2.08 83,356
2016-05-31 Memorial Sloan-kettering Cancer Center Sale 129,336 1.93 249,359
2016-05-26 Memorial Sloan-kettering Cancer Center Sale 40,068 1.93 77,251
2016-05-25 Memorial Sloan-kettering Cancer Center Sale 36,400 1.91 69,451
2016-04-26 Memorial Sloan-kettering Cancer Center Sale 6,500 1.96 12,740
2016-04-25 Memorial Sloan-kettering Cancer Center Sale 18,385 2.02 37,119
2016-04-22 Memorial Sloan-kettering Cancer Center Sale 27,692 2.08 57,460
2016-04-21 Memorial Sloan-kettering Cancer Center Sale 13,000 2.04 26,585
2016-04-20 Memorial Sloan-kettering Cancer Center Sale 33,497 2.02 67,663
2016-04-19 Memorial Sloan-kettering Cancer Center Sale 150,000 2.04 305,250
2016-04-18 Seth Sandesh Buy 6,500 1.99 12,902
2016-04-15 Seth Sandesh Buy 3,500 2.00 7,017
2016-04-15 Traversa Sergio Buy 1,000 2.02 2,020
2016-04-14 Nicholson, C. David Buy 5,000 2.00 10,000
2016-04-14 Seth Sandesh Buy 5,000 2.00 10,000
2016-04-14 Traversa Sergio Buy 2,000 2.02 4,040
2016-04-14 Dave Kaushik J (CEO and Interim CFO) Buy 10,000 2.02 20,150
2016-04-14 Steinhart Richard I Buy 2,500 2.01 5,024
2013-05-15 Mazanet Rosemary (Director) Buy 100 3.95 395

Insider trading activities including stock purchases, stock sales, and option exercises of ATNM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Actinium Pharmaceuticals, Inc. (symbol ATNM, CIK number 1388320) see the Securities and Exchange Commission (SEC) website.